Overall Fundamental outlook

Business Operations:

Sector: Financial Services
Industry: Insurance - Diversified

Star Health and Allied Insurance Company Limited provides health insurance products in India. It offers retail health insurance products for individuals, families, children, senior citizens, and persons with pre-existing medical conditions; group health insurance products for employer/employee and non-employer/employee groups, including small-to-medium enterprises; and personal accident and travel insurance products. The company also provides star women care insurance policy that provides surrogacy and oocyte donor covers; and star special care product that covers children diagnosed with autism and for outpatient specialized treatments. In addition, it offers star health assure insurance policy, star cancer care platinum insurance policy, star cardiac care insurance policy – platinum, young star extra protect – add-on cover, antyodaya shramik suraksha yojana, star group domestic travel insurance policy, smart health pro, star domestic travel insurance policy, as well as star group OPD care insurance product. The company offers its products through web aggregators, digital channels, agency channels, corporate agents, brokers, point of sale persons, insurance marketing firms, and other channels. Star Health and Allied Insurance Company was incorporated in 2005 and is based in Chennai, India.

Revenue projections:

Revenue projections for STARHEALTH
Revenue projections for STARHEALTH

STARHEALTH's projected revenue decline from last year is likely to make investors cautious. Lower revenues often hurt a company's bottom line, leading investors to be concerned about the company's ability to maintain profitability and deliver strong financial results in the future.

Financial Ratios:

currentRatio 0.000000
forwardPE 24.146254
debtToEquity 0.000000
earningsGrowth 188.000000
revenueGrowth 0.138000
grossMargins 0.212240
operatingMargins 0.032490
trailingEps 9.490000
forwardEps 21.728010

STARHEALTH's Forward PE ratio is favorable, meaning the stock price aligns well with earnings and isn't overvalued. This allows room for growth, making it an attractive investment for those seeking potential upside while ensuring the stock is not overpriced.
STARHEALTH's positive earnings and revenue growth indicate that the company is well-positioned for business expansion. This growth suggests a strong financial trajectory, with STARHEALTH expected to continue increasing its profits and revenue in the coming periods.
STARHEALTH's forward EPS exceeding its trailing EPS means the company is expected to be more profitable this year than last. This suggests an upward trend in earnings, with forecasts indicating that STARHEALTH's financial performance will improve in the current financial year.

Price projections:

Price projections for STARHEALTH
Price projections for STARHEALTH

STARHEALTH's price has consistently hovered around the lower limit of price projections. This pattern suggests that the stock may be underperforming relative to expectations, which could lead to concerns among investors.

Insider Transactions:

Insider Transactions for STARHEALTH
Insider Transactions for STARHEALTH


STARHEALTH had 6 buy transactions while market price was at 474.1333312988281 per share.There were no buy transactions during the given period.More sells than buys at STARHEALTH's current price levels suggest a potential downside. If this selling trend persists, it could trigger further price declines, as increased selling often reflects investor pessimism about the stock's future prospects.

Recommendation changes over time:

Recommendations trend for STARHEALTH
Recommendations trend for STARHEALTH


The analysts' recent buy bias for STARHEALTH indicates strong confidence in the stock's future performance. This could encourage more investors to view STARHEALTH as a worthwhile investment, positioning the company as a top choice for those seeking financial security and long-term growth opportunities.